Taiho Oncology

Drug Combination Meets Survival Endpoint in Phase III Pivotal Trial Involving Participants With Refractory Metastatic Colorectal Cancer

PARIS — Servier, Taiho Oncology, Inc., and Taiho Pharmaceutical Co., Ltd., announced today that th...

  • 2 years ago

Find us here

Get news from the Brandspace in your
inbox each weekday morning
  • Advertise with us : advertise@Brandspaceonline.com
  • Contact us at : contact@Brandspaceonline.com
  • Why you can trust Brandspace News
    • Lan »